M&A TRANSACTION · 2021
HistoTox Labs, Inc. acquired by Inotiv, Inc.
$22.4M· 7.6x EBITDA· 2.50x revenue
Target
HistoTox Labs, Inc.
Acquirer
Inotiv, Inc.
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$9.1M
EBITDA
$2.9M
Deal Value
$22.4M
EV/EBITDA
7.6x
Context
This $22.4M acquisition of HistoTox Labs, Inc. by Inotiv, Inc. sits in the laboratory services sub-vertical. The 7.6x EBITDA multiple paid in 2021 can be compared against the population median for laboratory services transactions of similar size on our Laboratory Services valuation hub. Inotiv, Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price laboratory services businesses on our Laboratory Services strategic buyer-pool page.
Source
Data sourced from SEC filings. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own laboratory services
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the HistoTox Labs, Inc. acquisition.